CHANGES IN ELASTOGRAPHY PARAMETERS IN PATIENTS WITH HEPATITIS C AFTER THE USE OF TRADITIONAL FOLK REMEDIES

Abstract
Background: Hepatitis C virus (HCV) infection often leads to progressive liver fibrosis, which can be non-invasively assessed by elastography. Despite the availability of direct-acting antivirals (DAAs), interest in complementary and alternative therapies remains high in many regions.
Objective: This study aimed to evaluate the effects of selected traditional folk remedies on liver stiffness as measured by transient elastography in patients with chronic HCV infection. Methods: A prospective, single-center study was conducted on 80 adult patients with chronic HCV. Patients in the intervention group (n=40) received a standardized regimen of herbal extracts (based on commonly used folk remedies), while the control group (n=40) received no additional herbal therapy. All patients were on standard antiviral therapy. Liver elastography (FibroScan®) was performed at baseline and at 12 weeks post-intervention. Biochemical markers (ALT, AST) and patient-reported outcomes were also recorded.
Results: Compared with controls, the intervention group demonstrated a modest but statistically significant reduction in liver stiffness values (mean difference -1.2 kPa, p=0.03). Improvements in serum ALT and AST levels were also observed, although these did not reach statistical significance (p>0.05). No serious adverse events were reported, and overall tolerability was high. Conclusion: The addition of certain traditional folk remedies to standard antiviral therapy may contribute to mild improvements in liver elasticity in patients with chronic HCV. Further large-scale, randomized controlled trials are needed to confirm these findings and elucidate mechanisms of action.
Keywords
folk medicine, traditional remedies, herbal therapy, milk thistle, antiviral activity, liver health.
References
- World Health Organization. Global Hepatitis Report. Geneva: WHO; 2017.
- European Association for the Study of the Liver (EASL). EASL Recommendations on Treatment of Hepatitis C. J Hepatol. 2020;73(5):1170-1218.
- Ozaras R, Tahan V. Update on Hepatitis C: Treatment of Chronic Hepatitis C. J Clin Transl Hepatol. 2020;8(2):1-10.
- Flora K, Hahn M, Rosen H, Benner K. Milk Thistle (Silybum marianum) for the Therapy of Liver Disease. Am J Gastroenterol. 1998;93(2):139-143.
- Yang EJ, Kim SS, Lee MJ. Anti-Inflammatory and Anti-Fibrotic Effects of Curcumin in Experimental Models of Liver Disease. Phytomedicine. 2019;59:152912.
- Arase Y, Ikeda K, Murashima N, et al. The Long-Term Efficacy of Glycyrrhizin in Patients with Chronic Hepatitis C. Cancer. 1997;79(8):1494-1500.
- Zaynobidin o’g’li, Sotvoldiyev Muzaffar. "MEASURES TO FIGHT THE EPIDEMIC." Ethiopian International Journal of Multidisciplinary Research 11, no. 03 (2024): 261-263.
- Bakhodirovna, Mirzakarimova Dildora, and Abdukodirov Sherzodjon Taxirovich. "CHARACTERISTICS OF RHINOVIRUS INFECTION." International journal of medical sciences 4, no. 08 (2024): 55-59.
- Mirzakarimova, D. B., Hodjimatova, G. M., & Abdukodirov, S. T. (2024). FEATURES OF PATHOGENESIS, CLINICAL PICTURE AND DIAGNOSIS OF CO-INFECTION OF THE LIVER WITH HEPATITIS B AND C VIRUSES. International Multidisciplinary Journal for Research & Development, 11(02).
- Castéra L, Foucher J, Bernard PH, et al. Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations. Hepatology. 2010;51(3):828-835.
- Curry MP, Tapper EB. Hepatitis C Virus. BMJ. 2015;350:g7809.